An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare service payer perspective.

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Innovations in public health and health economics (1) Health Economics ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by